Julian Rong
Overview
Explore the profile of Julian Rong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clark P, Valery P, Strasser S, Weltman M, Thompson A, Levy M, et al.
Drug Alcohol Rev
. 2024 Aug;
43(6):1559-1572.
PMID: 39091194
Introduction: Alcohol use is common in patients with chronic hepatitis C virus (HCV) infection. We examined the impact of alcohol use on direct-acting antiviral (DAA) therapy outcome and the clinical...
2.
Clark P, Valery P, Strasser S, Weltman M, Thompson A, Levy M, et al.
J Gastroenterol Hepatol
. 2023 Dec;
39(3):568-575.
PMID: 38114452
Background: Direct-acting antiviral (DAA) therapies for hepatitis C virus infection (HCV) lead to excellent rates of sustained virological response (SVR). However, loss to follow-up (LTFU) for SVR testing remains a...
3.
Clark P, Valery P, Ward J, Strasser S, Weltman M, Thompson A, et al.
BMC Gastroenterol
. 2022 Jul;
22(1):339.
PMID: 35820850
Background: First Nations Peoples of Australia are disproportionally affected by hepatitis C (HCV) infection. Through a prospective study we evaluated the outcome of direct-acting antiviral (DAA) therapy among First Nations...
4.
Clark P, Valery P, Strasser S, Weltman M, Thompson A, Levy M, et al.
Dig Dis Sci
. 2022 May;
68(1):291-303.
PMID: 35552941
Background And Aims: In 2016, direct-acting antiviral (DAA) treatment for hepatitis C (HCV) became available through Australia's universal health care system, with the aim of HCV elimination. We report real-world...